BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24005577)

  • 1. Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction.
    Parker AL; White KM; Lavery CA; Custers J; Waddington SN; Baker AH
    Gene Ther; 2013 Dec; 20(12):1158-64. PubMed ID: 24005577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors.
    Greig JA; Buckley SM; Waddington SN; Parker AL; Bhella D; Pink R; Rahim AA; Morita T; Nicklin SA; McVey JH; Baker AH
    Mol Ther; 2009 Oct; 17(10):1683-91. PubMed ID: 19603000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo properties of adenovirus vectors with increased affinity to CD46.
    Wang H; Liu Y; Li Z; Tuve S; Stone D; Kalyushniy O; Shayakhmetov D; Verlinde CL; Stehle T; McVey J; Baker A; Peng KW; Roffler S; Lieber A
    J Virol; 2008 Nov; 82(21):10567-79. PubMed ID: 18753195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.
    Shayakhmetov DM; Papayannopoulou T; Stamatoyannopoulos G; Lieber A
    J Virol; 2000 Mar; 74(6):2567-83. PubMed ID: 10684271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus serotype 30 fiber does not mediate transduction via the coxsackie-adenovirus receptor.
    Law LK; Davidson BL
    J Virol; 2002 Jan; 76(2):656-61. PubMed ID: 11752156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of adenovirus serotype 35 vectors using genetically modified animals and non-human primates].
    Sakurai F; Kawabata K; Mizuguchi H
    Yakugaku Zasshi; 2006 Nov; 126(11):1013-9. PubMed ID: 17077607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence of adenovirus infectivity on length of the fiber shaft domain.
    Shayakhmetov DM; Lieber A
    J Virol; 2000 Nov; 74(22):10274-86. PubMed ID: 11044071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.
    Stepanenko AA; Chekhonin VP
    Virus Res; 2018 Sep; 257():40-51. PubMed ID: 30125593
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Hemsath JR; Liaci AM; Rubin JD; Parrett BJ; Lu SC; Nguyen TV; Turner MA; Chen CY; Cupelli K; Reddy VS; Stehle T; Liszewski MK; Atkinson JP; Barry MA
    J Virol; 2022 Feb; 96(3):e0082621. PubMed ID: 34787457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
    Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
    J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced antitumor efficacy of fiber-modified, midkine promoter-regulated oncolytic adenovirus in human malignant mesothelioma.
    Takagi-Kimura M; Yamano T; Tamamoto A; Okamura N; Okamura H; Hashimoto-Tamaoki T; Tagawa M; Kasahara N; Kubo S
    Cancer Sci; 2013 Nov; 104(11):1433-9. PubMed ID: 23962292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus.
    Granio O; Porcherot M; Corjon S; Kitidee K; Henning P; Eljaafari A; Cimarelli A; Lindholm L; Miossec P; Boulanger P; Hong SS
    J Virol; 2009 Jun; 83(12):6048-66. PubMed ID: 19357170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy.
    Han T; Tang Y; Ugai H; Perry LE; Siegal GP; Contreras JL; Wu H
    Virol J; 2007 Oct; 4():103. PubMed ID: 17958897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting CD46 Enhances Anti-Tumoral Activity of Adenovirus Type 5 for Bladder Cancer.
    Do MH; To PK; Cho YS; Kwon SY; Hwang EC; Choi C; Cho SH; Lee SJ; Hemmi S; Jung C
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
    Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
    J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus vectors composed of subgroup B adenoviruses.
    Sakurai F; Kawabata K; Mizuguchi H
    Curr Gene Ther; 2007 Aug; 7(4):229-38. PubMed ID: 17969556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway.
    Tsuruta Y; Pereboeva L; Glasgow JN; Rein DT; Kawakami Y; Alvarez RD; Rocconi RP; Siegal GP; Dent P; Fisher PB; Curiel DT
    Clin Cancer Res; 2007 May; 13(9):2777-83. PubMed ID: 17473211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors.
    Alba R; Bradshaw AC; Coughlan L; Denby L; McDonald RA; Waddington SN; Buckley SM; Greig JA; Parker AL; Miller AM; Wang H; Lieber A; van Rooijen N; McVey JH; Nicklin SA; Baker AH
    Blood; 2010 Oct; 116(15):2656-64. PubMed ID: 20610817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies.
    Uusi-Kerttula H; Davies J; Coughlan L; Hulin-Curtis S; Jones R; Hanna L; Chester JD; Parker AL
    Oncotarget; 2016 May; 7(19):27926-37. PubMed ID: 27056886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.